Literature DB >> 24950694

Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?

Helmut Schühlen1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24950694     DOI： 10.1093/eurheartj/ehu202

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  11 in total

Review 1.  Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Adnan I Qureshi; Iryna Lobanova; Wei Huang; Muhammad F Ishfaq; Joseph P Broderick; Christy N Cassarly; Renee H Martin; R Loch Macdonald; Jose I Suarez
Journal:  Neurocrit Care       Date:  2021-12-23       Impact factor: 3.210

2.  Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial.

Authors:  John J Miklavcic; Kimberly D Fraser; Jenny Ploeg; Maureen Markle-Reid; Kathryn Fisher; Amiram Gafni; Lauren E Griffith; Sandra Hirst; Cheryl A Sadowski; Lehana Thabane; Jean A C Triscott; Ross Upshur
Journal:  BMC Geriatr       Date:  2020-05-13       Impact factor: 3.921

3.  The Impact of Iron Supplementation for Treating Anemia in Patients with Chronic Kidney Disease: Results from Pairwise and Network Meta-Analyses of Randomized Controlled Trials.

Authors:  Marcel Adler; Francisco Herrera-Gómez; Débora Martín-García; Marie Gavid; F Javier Álvarez; Carlos Ochoa-Sangrador
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-30

4.  Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?

Authors:  Chiedozie I Udeh; Jing You; Matthew R Wanek; Jarrod Dalton; Belinda L Udeh; Sevag Demirjian; Nadeem Rahman; J Steven Hata
Journal:  Perioper Med (Lond)       Date:  2018-12-14

5.  Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses.

Authors:  Francisco Herrera-Gómez; M Montserrat Chimeno; Débora Martín-García; Frank Lizaraso-Soto; Álvaro Maurtua-Briseño-Meiggs; Jesús Grande-Villoria; Juan Bustamante-Munguira; Eric Alamartine; Miquel Vilardell; Carlos Ochoa-Sangrador; F Javier Álvarez
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

6.  Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.

Authors:  Jadwiga A Wedzicha; Dave Singh; Ioanna Tsiligianni; Christine Jenkins; Sebastian Fucile; Robert Fogel; Steven Shen; Pankaj Goyal; Karen Mezzi; Konstantinos Kostikas
Journal:  Respir Res       Date:  2019-01-08

7.  The Association between Alcohol Consumption and Serum Metabolites and the Modifying Effect of Smoking.

Authors:  Julia Langenau; Heiner Boeing; Manuela M Bergmann; Ute Nöthlings; Kolade Oluwagbemigun
Journal:  Nutrients       Date:  2019-10-01       Impact factor: 5.717

8.  Measuring the effects of a personalized music intervention on agitated behaviors among nursing home residents with dementia: design features for cluster-randomized adaptive trial.

Authors:  Ellen M McCreedy; Roee Gutman; Rosa Baier; James L Rudolph; Kali S Thomas; Faye Dvorchak; Rebecca Uth; Jessica Ogarek; Vincent Mor
Journal:  Trials       Date:  2021-10-07       Impact factor: 2.279

9.  Age-Dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-Associated Thrombosis in Critically Ill Children: A Post Hoc Analysis of a Bayesian Phase 2b Randomized Clinical Trial.

Authors:  E Vincent S Faustino; Leslie J Raffini; Sheila J Hanson; Jill M Cholette; Matthew G Pinto; Simon Li; Sarah B Kandil; Marianne E Nellis; Veronika Shabanova; Cicero T Silva; Joana A Tala; Tara McPartland; Philip C Spinella
Journal:  Crit Care Med       Date:  2021-04-01       Impact factor: 9.296

10.  Why driving pressure is not associated with the mortality in non-ARDS patients?

Authors:  Huixue Huang; Hangyong He
Journal:  Crit Care       Date:  2020-04-14       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.